News & Events

Expert shares advances and opportunities for genetic editing

November 8, 2018

Genome engineering was the subject of the day as Arizona State University’s Biodesign Institute kicked off a new lecture series designed to bring science’s preeminent thought leaders to ASU. The Arntzen Grand Challenges Lecture Series launched on Nov. 1 with a presentation by Samuel Sternberg, co-author of A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution—the premiere text on the emergence and future of genetic editing. CRISPR is a revolutionary tool...

National Cancer Institute awards Carlo Maley $10.8M grant

November 1, 2018

When Carlo Maley first delved into his studies on the evolution of disease, he was struck with how little the field had been explored. He decided that his skills in evolution and computational biology would be well-suited for the job. “I went to PubMed and looked for all papers that had both cancer and evolution in the title … and I only came up with a handful of hits. It became clear that evolution is fundamental to the basic science of cancer, which explains why people have such a...

Escape from the lab! Six promising biotech start-up companies profiled at all-day symposium

October 1, 2018

  ASU’s many laboratories are seedbeds for an astonishing variety of new ideas. But the path from basic research to real-world applications can be complex, perilous and sometimes, bewildering. Recently, an all-day seminar, hosted at the Biodesign Institute, explored an array of promising research that has escaped the confines of the lab. New spinout companies, based on pathbreaking research, are bringing exciting innovations in the life sciences to market. The gathering was...

Farewell flat biology – tackling infectious disease using 3-D tissue engineering

September 10, 2018

In a new invited review article, ASU Biodesign microbiologists and tissue engineers Cheryl Nickerson, Jennifer Barrila and colleagues discuss the development and application of three-dimensional (3-D) tissue culture models as they pertain to infectious disease. They describe these models as predictive pre-clinical platforms to study host-pathogen interactions, infectious disease mechanisms, and antimicrobial drug development.   The review, entitled “Modeling Host-Pathogen...

Plants produce ‘green vaccine’ against norovirus

July 25, 2018

Each year, close to 700 million people are stricken with a viral infection that causes vomiting, diarrhea and stomach pain. While the majority will recover in a few days, some 200,000 infected patients will die. The culprit is known as norovirus—often referred to as 'the cruise ship illness'. Currently, no recommended treatments or vaccines are available.  In a new study, Andrew G. Diamos and Hugh S. Mason of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy describe a...

Space business is big business

March 28, 2018

Once, space was a vast emptiness beyond earth, hostile and remote. Today, space is humming with satellites essential for global telecommunications and human occupied vehicles that provide an innovative platform for cutting edge scientific research that is benefiting life in space and on Earth. Indeed, many Earth-bound innovations have benefited from space research, from advanced solar cells to developments in parallel computing and major advances in human health. In a path-breaking new...

New Biodesign Travel Grants send students to Japan, Chicago, Palm Springs

March 21, 2018

Five students affiliated with Arizona State University’s Biodesign Institute are the first recipients of the new Biodesign Student Travel Grant. The funding for this program was received from ASU Sun Devil Giving Day, a university-wide event in which Sun Devils from campus and all over the world are invited to show support for the university by engaging in online giving. Supporting students as they travel to career-building conferences is just one way to participate in 2018’s Sun Devil...

Gemneo Bioscience receives entrepreneurship award from Flinn Foundation

March 1, 2018

Gemneo Bioscience, a genomics technology company seeking to revolutionize diagnosis and treatment for cancer and other diseases, was named last week as one of six Arizona bioscience startup firms that will participate in the Flinn Foundation’s 2018 Bioscience Entrepreneurship Program. Gemneo will receive $30,000 in funding support and program services through a nonprofit partner. Gemneo was selected from 30 applicants, a record for the program. “The six companies chosen this year are...

ASU's Biodesign Institute hosts thousands of visitors for Open Door 2018

February 27, 2018

More than 2,600 people walked the halls of Arizona State University’s Biodesign Institute Saturday during the seventh annual ASU Open Door event. Kids of all ages and their families enjoyed nearly 40 science exhibits and activities organized by 16 research centers at Biodesign.  Guests had the chance to take a selfie and watch their face evolve with computer software, put on a spacesuit and do a microbiology experiment on the International Space Station, see how treatments to fight...

Triple-negative Breast Cancer: What Have We Learned, How Can We Innovate?

January 25, 2018

Presented by Jasgit Sachdev, M.D., Medical Oncologist and Clinical Trial Investigator, Virginia G. Piper Cancer Center Clinical Trials, Honor Health Research Institute Jasgit Sachdev leads the Honor Health Research Institute program in new drug development for breast and gynecologic cancers and has been actively engaged in clinical and translational research with a particular focus in triple negative breast cancer. She has served as the principal investigator on several...